Chiro.Org is proud to support the FCER and the ICPA and their continuing research into the health benefits of chiropractic care. Please offer them your financial assistance!
Chiropractic Research Results for Cancer
Alternatives in Cancer Pain Treatment: The Application of Chiropractic Care
Semin Oncol Nurs 2005 (Aug); 21 (3): 184–189
The judicial use of chiropractic services in cancer patients appears to offer many economical and effective strategies for reducing the pain and suffering of cancer patients, as well as providing the potential to improve patient health overall. You'll find more articles like this in the Pain Management Page.
Chronic Pain in Persons With Neuromuscular Disease
Clin J Pain 2005 (Jan); 21 (1): 18–26
In this paper, researchers in a medical school rehabilitation department were interested in finding out what treatments were most effective at reducing pain for neuromuscular diseases (like amyotrophic lateral sclerosis and myotonic muscular dystrophies). Interestingly, chiropractic scored the highest relief rating (7.33 out of 10), scoring higher than the relief provided by these medical treatments: nerve blocks (6.75) or Opioid analgesics (6.37). WOW!!!
The Chiropractor's Role in Pain Management for Oncology Patients
J Manipulative Physiol Ther 2001; 24 (1) Jan: 52–57
This article describes the potential benefits of chiropractic for cancer patients in the area of pain management and quality of life. Two specific case studies are presented in which cancer patients' quality of life benefited from chiropractic treatment.
The Use of Complementary and Alternative Medical Providers by Insured Cancer Patients in Washington State
Cancer 2004 (Apr 1); 100 (7): 1522–1530
Musculoskeletal pain was the most common diagnosis at the CAM provider visit. Billed amounts for alternative services were <2% of the overall medical bills for cancer patients. A substantial number of insured cancer patients will use alternative providers if they are given the choice. The cost of this treatment is modest compared with conventional care charges. For individuals with cancer, CAM providers do not appear to be replacing conventional providers but instead are integrated into overall care.
Ascorbic Acid in the Prevention and Treatment of Cancer
Alternative Medicine Review 1998 (Jun); 3 (3): 174–186 ~ FULL TEXT
Proposed mechanisms of action for ascorbic acid (ascorbate, vitamin C) in the prevention and treatment of cancer include enhancement of the immune system, stimulation of collagen formation necessary for "walling off" tumors, inhibition of hyaluronidase which keeps the ground substance around the tumor intact and prevents metastasis, prevention of oncogenic viruses, correction of an ascorbate deficiency often seen in cancer patients, expedition of wound healing after cancer surgery, enhancement of the effect of certain chemotherapy drugs, reduction of the toxicity of other chemotherapeutic agents such as Adriamycin, prevention of free radical damage, and neutralization of carcinogenic substances.
Nutritional Support for Chronic Myelogenous and Other Leukemias: A Review of the Scientific Literature
Alternative Medicine Review 2002 (Oct); 7 (5): 404–409 ~ FULL TEXT
Chronic myelogenous leukemia (CML) is a slowly progressive disease characterized by the overproduction of granulocytes (neutrophils, eosinophils, and basophils). A blood smear shows moderate elevations in white blood cell counts that may persist for years and be benign. Platelets are increased in number, although their function is impaired, resulting in symptoms of easy bleeding (purpura, swollen gums). Conventional medical treatment is a marrow transplant and alkylating agents, which are usually prescribed only during crisis. Several nutrients and botanicals have been studied for use in CML, including vitamin A and all-trans retinoic acid (Retin-A), vitamin D3, vitamin E, vitamin B12, indirubin (found in herbs including Indigofera tinctoria and Isatis tinctoria), and Curcuma longa. This article briefly reviews the scientific literature on the therapeutic use of these nutrients for CML.
Green Tea (Camellia Sinensis) Extract and Its Possible Role in the Prevention of Cancer
Alternative Medicine Review 1999 (Oct); 4 (5): 360–370 ~ FULL TEXT
The American Cancer Society estimates that in the 1980s more than 4. 5 million Americans died of cancer. In addition, there were nearly nine million new cases and about 12 million people were under medical care for cancer. With cancer being the second most common cause of death in the United States population, the possibility that readily-available natural substances may be beneficial in the prevention of cancer warrants closer examination. A growing body of research has demonstrated green tea polyphenols to be powerful antioxidants with anticarcinogenic properties. These polyphenolic compounds, specifically the catechins epigallocatechin-3-gallate (EGCG), epigallocatechin (EGC), and epicatechin-3-gallate (ECG), which account for 30-40 percent of the extractable solids of green tea leaves, are believed to mediate many of the cancer chemopreventive effects. Mechanisms of action may include antioxidant and free-radical scavenging activity, and stimulation of detoxification systems through selective induction or modification of phase I and phase II metabolic enzymes.
Part I: Their Actions and Interactions With Oncologic Therapies
Alternative Medicine Review 1999 (Oct); 4 (5): 304–329 ~ FULL TEXT
Dietary and endogenous antioxidants prevent cellular damage by reacting with and eliminating oxidizing free radicals. However, in cancer treatment, a mode of action of certain chemotherapeutic agents involves the generation of free radicals to cause cellular damage and necrosis of malignant cells. So a concern has logically developed as to whether exogenous antioxidant compounds taken concurrently during chemotherapy could reduce the beneficial effect of chemotherapy on malignant cells. The importance of this concern is underlined by a recent study which estimates 23 percent of cancer patients take antioxidants. 1
Part II: Quick Reference Guide
Alternative Medicine Review 2000 (Apr); 5 (2): 152–163 ~ FULL TEXT
This guide is meant to be a companion to the previous review on effects of antioxidant supplementation during cancer therapy. (1) Widespread use of antioxidant compounds makes this an area of increasing interest to oncologists as well as other physicians; hence, the attempt to reduce the findings of a lengthy report to a manageable guide.
Part III: Quercetin
Alternative Medicine Review 2000 (Jun); 5 (3): 196–204 ~ FULL TEXT
Quercetin is the major bioflavonoid in the human diet. The estimated average daily dietary intake of quercetin by an individual in the United States is 25 mg. (3) Its reputation as an antioxidant stems from the reactivity of phenolic compounds with free radical species to form phenoxy radicals which are considerably less reactive. Additionally, one can envision a polyphenolic compound easily oxidizable to a quinoid form (similar to vitamin K) and participating in the redox chemistry of nature.
Part I: Human Chemoprevention Trials
Alternative Medicine Review 2001 (Feb); 6 (1): 7–19 ~ FULL TEXT
The battle against cancer has been waged for several decades without resounding curative success from the use of chemotherapy or radiotherapy in most common solid tumors. (1) Much of the present day research directed against active malignancy has shifted toward identification of strategies affecting the growth rate or apoptosis of such cells so that life with cancer can be greatly extended without the deleterious effects of the more aggressive therapies. The large majority of malignancies are attributable to dietary and lifestyle factors. (2) In addition there are many environmental chemical factors suspected of playing a sizable role in the occurrence of malignancies. (3) Given the poor success rate for treatment of most common tumors, it seems logical to focus attention on ways to prevent cancer occurrence.
Part II: Preclinical Data and Chemoprevention for Common Cancers
Alternative Medicine Review 2001 (Apr); 6 (2): 167–187 ~ FULL TEXT
In the present paper the mechanisms of action of promising treatments will be discussed. In vitro and animal data are presented in support of the agents as appropriate. The subject of chemoprevention with nutritional agents has been the subject of voluminous research, and this review should not be considered exhaustive. In cases where review articles already exist regarding a particular agent (e.g., vitamin A, beta-carotene), these papers should be consulted for a more complete summary.
![[Red Diagonal Ball]](../GRAPHICS/red-diam.gif){kind=small}
![[SWIRL 2]](../GRAPHICS/SWIRL-2.GIF)